lipids drugs
Showing 1 - 25 of >10,000
Healthy Trial in Philadelphia (Blood draw)
Active, not recruiting
- Healthy
- Blood draw
-
Philadelphia, PennsylvaniaThe Clinical Translational Research Center (CTRC) at the Hospita
Aug 16, 2022
Hepatitis B, Chronic, Lipid Disorder Trial in Wuhan (oral Tenofovir Amibufenamide 25mg each day, lipid lowering drugs (e.g.
Enrolling by invitation
- Hepatitis B, Chronic
- Lipid Disorder
- oral Tenofovir Amibufenamide 25mg each day
- lipid lowering drugs (e.g. Atorvastatin and amlodipine.)
-
Wuhan, Hubei, ChinaWuhan Union hosipital
May 25, 2022
Physical Activity, Healthy Trial in Bergen (Cod meal from residual material, Control)
Completed
- Physical Activity
- Healthy
- Cod meal from residual material
- Control
-
Bergen, NorwayOddrun Anita Gudbrandsen
Mar 29, 2022
Alzheimer Trial in Auburn (Extra virgin olive oil)
Not yet recruiting
- Alzheimer Disease
- Extra virgin olive oil
-
Auburn, AlabamaAuburn University
Jul 1, 2023
Sjogren-Larsson Syndrome Trial in Omaha (ADX-629)
Recruiting
- Sjogren-Larsson Syndrome
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Nov 7, 2022
Memory Disorders, Anxiety Depression, Sleep Trial in Zarqa (Coriandrum sativum seeds)
Completed
- Memory Disorders
- +2 more
- Coriandrum sativum seeds
-
Zarqa, JordanFaculty of Pharmaceutical Sciences
Aug 11, 2023
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Cholesterol metabolism disruption
-
Quebec city, Quebec, CanadaCHU de Québec-Université Laval
Oct 17, 2022
Type 2 Diabetes (T2DM) Trial in Nanjing (Endovascular denervation System (Generator and Catheter ))
Recruiting
- Type 2 Diabetes Mellitus (T2DM)
- Endovascular denervation System (Generator and Catheter )
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Southeast University
Jan 2, 2023
HIV Trial in United States (AL 721)
Completed
- HIV Infections
- AL 721
-
Los Angeles, California
- +8 more
Oct 28, 2021
Non-Alcoholic Fatty Liver Disease Trial in Giza (conventional treatment, Furosemide or other alternatives , Niaspan or other
Recruiting
- Non-Alcoholic Fatty Liver Disease
- conventional treatment
- +2 more
-
Giza, October 6, EgyptMaha Youssif Fekry
Nov 18, 2023
Hypertension, Drug Therapy, Primary Health Care Trial in Gothenburg, Skövde (Time of ordinary antihypertensive medication
Not yet recruiting
- Hypertension
- +2 more
- Time of ordinary antihypertensive medication intake
-
Gothenburg, Sweden
- +2 more
Apr 4, 2022
Hemodialysis Access Failure Trial in Shanghai (pcsk9 inhibitor)
Recruiting
- Hemodialysis Access Failure
- pcsk9 inhibitor
-
Shanghai, Pudong, ChinaYuanyuan Xie
Sep 10, 2023
Novel Antidiabetic Drug Combined With Angiotensin
Recruiting
- Type 2 Diabetes
- Antidiabetic Drugs
-
Beijing, Beijing, China
- +1 more
Jun 20, 2023
Cardiometabolic Health Trial in Kallithea (Conventional burger, Vegan burger)
Recruiting
- Cardiometabolic Health
- Conventional burger
- Vegan burger
-
Kallithea, Attica, GreeceDepartment of Nutrition and Dietetics, School of Health Sciences
Oct 13, 2022
HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)
Recruiting
- HIV-1-infection
- Multi-Antiviral Resistance
- REGISTER CREATION
-
Milan, MI, ItalyOspedale San Raffaele
Dec 22, 2021
Diabetes Type 2 Trial in Seongnam (Dapagliflozin 10mg Tab, Lobeglitazone 0.5 mg, Dapagliflozin + Lobeglitazone)
Recruiting
- Diabetes Type 2
- Dapagliflozin 10mg Tab
- +2 more
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Jun 14, 2023
Healthy Trial (healthy volunteers blood sampling)
Not yet recruiting
- Healthy
- healthy volunteers blood sampling
- (no location specified)
Aug 29, 2023
HIV, Pregnancy Related, Mother to Child Transmission Trial in Salvador (Dolutegravir plus lamivudine in a FDC)
Recruiting
- HIV Infections
- +2 more
- Dolutegravir plus lamivudine in a FDC
-
Salvador, BA, BrazilFundação Bahiana de Infectologia
Feb 3, 2022
NIDDM, Obesity Trial in Los Angeles (Metformin Extended Release (ER) Oral Tablet, Placebo)
Not yet recruiting
- NIDDM
- Obesity
- Metformin Extended Release (ER) Oral Tablet
- Placebo
-
Los Angeles, CaliforniaUCLA Center for Human Nutrition
Jul 17, 2023
Type 2 Diabetes Trial in Xuzhou (GLP-1 receptor agonist)
Recruiting
- Type 2 Diabetes Mellitus
- GLP-1 receptor agonist
-
Xuzhou, Jiangsu, ChinaDepartment of Endocrinology
Apr 16, 2022
Fatty Liver Disease, Fatty Liver Trial in Giza (Itopride, conventional therapy)
Recruiting
- Fatty Liver Disease
- Fatty Liver
- Itopride
- conventional therapy
-
Giza, EgyptMaha Youssif Fekry
Jul 28, 2023
Coronary Artery Stenosis Trial in Tehran (Anthocyanin-rich diet)
Not yet recruiting
- Coronary Artery Stenosis
- Anthocyanin-rich diet
-
Tehran, Iran, Islamic Republic ofShahid Modares Hospital
Aug 16, 2023
Healthy Trial in Lund (Polar lipid 1, Polar lipid 2, Non-polar lipids)
Recruiting
- Healthy
- Polar lipid 1
- +3 more
-
Lund, Välj..., SwedenLund University, dep of Food Technology, Engineering, and Nutrit
Nov 28, 2023